Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Oncogene
|
August 31, 2004
An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy
Ningxi Zhu, Lubing Gu, Harry W Findley, et al.
Frontiers in Oncology
|
December 12, 2022
MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma
Tao Liu, Lubing Gu, Zhongzhi Wu, et al.
Oncogene
|
November 7, 2003
Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53
Muxiang Zhou, Lubing Gu, Ningxi Zhu, et al.
Molecular Cancer
|
April 19, 2015
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
Tao Liu, Hailong Zhang, Jing Xiong, et al.
Plos One
|
June 27, 2014
Inhibition of MDM2 by nilotinib contributes to cytotoxicity in both Philadelphia-positive and negative acute lymphoblastic leukemia
Hailong Zhang, Lubing Gu, Tao Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
November 2, 2002
Study on the expression of IkappaB-alpha protein in TNF-alpha induced apoptosis of U937 cells
Weihua Chen, Guangjie Peng, Aiping Tang, et al.
The Journal of Biological Chemistry
|
October 8, 2004
Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively
Lubing Gu, Ningxi Zhu, Harry W Findley, et al.
Experimental Hematology
|
May 30, 2007
Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines
Lubing Gu, Kuang-Yueh Chiang, Ningxi Zhu, et al.
Molecular Cancer Therapeutics
|
December 18, 2012
Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway
Mei Huang, Hailong Zhang, Tao Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 26, 2010
Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types
Xiang Ling, Diane Calinski, Asher A Chanan-Khan, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Oncogene
|
August 31, 2004
An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy
Ningxi Zhu, Lubing Gu, Harry W Findley, et al.
Frontiers in Oncology
|
December 12, 2022
MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma
Tao Liu, Lubing Gu, Zhongzhi Wu, et al.
Oncogene
|
November 7, 2003
Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53
Muxiang Zhou, Lubing Gu, Ningxi Zhu, et al.
Molecular Cancer
|
April 19, 2015
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
Tao Liu, Hailong Zhang, Jing Xiong, et al.
Plos One
|
June 27, 2014
Inhibition of MDM2 by nilotinib contributes to cytotoxicity in both Philadelphia-positive and negative acute lymphoblastic leukemia
Hailong Zhang, Lubing Gu, Tao Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
November 2, 2002
Study on the expression of IkappaB-alpha protein in TNF-alpha induced apoptosis of U937 cells
Weihua Chen, Guangjie Peng, Aiping Tang, et al.
The Journal of Biological Chemistry
|
October 8, 2004
Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively
Lubing Gu, Ningxi Zhu, Harry W Findley, et al.
Experimental Hematology
|
May 30, 2007
Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines
Lubing Gu, Kuang-Yueh Chiang, Ningxi Zhu, et al.
Molecular Cancer Therapeutics
|
December 18, 2012
Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway
Mei Huang, Hailong Zhang, Tao Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 26, 2010
Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types
Xiang Ling, Diane Calinski, Asher A Chanan-Khan, et al.
Page
of 5